NIPPON CHEMIPHAR CO., LTD. Logo

NIPPON CHEMIPHAR CO., LTD.

Develops generic drugs, allergy treatments, and novel pharmaceuticals for a global market.

4539 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区岩本町二丁目2番3号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Nippon Chemiphar Co., Ltd. is a pharmaceutical company engaged in the manufacture, sale, import, and export of ethical pharmaceuticals, diagnostic agents, and health-related products. The company's business is centered on three strategic pillars: the development of high-quality generic drugs; the commercialization of innovative products derived from its core technologies in the allergy field; and the creation of novel drugs based on proprietary technologies and know-how, such as alkalization therapy. Nippon Chemiphar aims to provide solutions that help people maintain their health and is actively pursuing the global expansion of its three core business areas.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for NIPPON CHEMIPHAR CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-20 03:58
Regulatory News Service
臨時報告書
Japanese 30.9 KB
2025-06-20 03:57
Regulatory News Service
内部統制報告書-第93期(2024/04/01-2025/03/31)
Japanese 23.8 KB
2025-06-20 03:57
Regulatory News Service
確認書
Japanese 8.6 KB
2025-06-20 03:56
Annual Report
有価証券報告書-第93期(2024/04/01-2025/03/31)
Japanese 1.2 MB
2024-11-13 01:21
Interim Report
半期報告書-第93期(2024/04/01-2025/03/31)
Japanese 223.1 KB
2024-11-13 01:21
Regulatory News Service
確認書
Japanese 8.7 KB
2024-06-24 08:03
Regulatory News Service
臨時報告書
Japanese 18.7 KB
2024-06-24 03:28
Regulatory News Service
臨時報告書
Japanese 25.6 KB
2024-06-24 03:27
Regulatory News Service
確認書
Japanese 8.6 KB
2024-06-24 03:26
Regulatory News Service
内部統制報告書-第92期(2023/04/01-2024/03/31)
Japanese 23.2 KB
2024-06-24 03:24
Annual Report
有価証券報告書-第92期(2023/04/01-2024/03/31)
Japanese 1.2 MB
2024-02-13 04:31
Regulatory News Service
確認書
Japanese 8.7 KB
2024-02-13 04:30
Quarterly Report
四半期報告書-第92期第3四半期(2023/10/01-2023/12/31)
Japanese 230.5 KB
2023-11-15 02:46
Major Shareholding Notification
大量保有報告書
Japanese 38.2 KB
2023-11-13 01:07
Regulatory News Service
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all NIPPON CHEMIPHAR CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NIPPON CHEMIPHAR CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan 4575
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
CellSeed Inc. Logo
Develops cell sheet products, culture equipment, and offers contract manufacturing services.
Japan 7776
CellSource Co.,Ltd. Logo
Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.
Japan 4880
Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland CLN
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark CESSA

Talk to a Data Expert

Have a question? We'll get back to you promptly.